MDM2 309 T/G polymorphism is associated with colorectal cancer risk especially in Asians: A meta-analysis

Medical Oncology

Volumn 28, Issue 4, 2011, Pages 981-985

  Fang, Fang ^a   Yu, Xiao Jia ^a   Yu, Lu ^a   Yao, Lei ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

309 T G; Colorectal cancer risk; MDM2; Meta analysis; Polymorphism

Indexed keywords

PROTEIN MDM2;

ALLELE; ARTICLE; ASIAN; CANCER RISK; COLORECTAL CANCER; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; POPULATION GENETICS; PRIORITY JOURNAL;

ASIAN CONTINENTAL ANCESTRY GROUP; COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-MDM2; RISK FACTORS;

EID: 84655175123     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9577-1     Document Type: Article

References (20)

1. J Momand GP Zambetti DC Olson D George AJ Levine 1992 The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation Cell 69 1237 1245
2. D Michael M Oren 2003 The p53-Mdm2 module and the ubiquitin system Semin Cancer Biol 13 49 58
3. GL Bond 2004 A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans Cell 119 591 602
4. O Nunobiki 2009 Polymorphisms of p53 codon 72 and MDM2 promoter 309 and the risk of endometrial cancer Hum Cell 22 101 106
5. KP Economopoulos TN Sergentanis 2010 Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis Breast Cancer Res Treat 120 211 216
6. S Kang 2009 Association of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancer in Chinese women Int J Gynecol Cancer 19 572 577
7. M Ueda 2009 Murine double-minute 2 homolog single nucleotide polymorphism 309 and the risk of gynecologic cancer Hum Cell 22 49 54
8. SD Markowitz MM Bertagnolli 2009 Molecular origins of cancer: molecular basis of colorectal cancer N Engl J Med 361 2449 2460
9. S Wilkening JL Bermejo K Hemminki 2007 MDM2 SNP309 and cancer risk: a combined analysis Carcinogenesis 28 2262 2267
10. J Lau JP Ioannidis CH Schmid 1997 Quantitative synthesis in systematic reviews Ann Intern Med 127 820 826
11. N Mantel W Haenszel 1959 Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 719 748
12. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 177 188
13. M Egger SG Davey M Schneider C Minder 1997 Bias in meta-analysis detected by a simple, graphical test BMJ 315 629 634
14. P Alhopuro 2005 The MDM2 promoter polymorphism SNP309T → G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck J Med Genet 42 694 698
15. K Sotamaa 2005 p53 codon 72 and MDM2 SNP309 polymorphisms and age of colorectal cancer onset in Lynch syndrome Clin Cancer Res 11 6840 6844
16. C Menin 2006 Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status J Natl Cancer Inst 98 285 288
17. H Alazzouzi 2007 Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells J Med Genet 44 75 80
18. BA Talseth 2007 MDM2 SNP309 T > G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients Int J Cancer 120 563 565
19. JN Liu 2008 Genetic polymorphism in MDM2 is associated with susceptibility to colorectal cancer in a Chinese population Zhonghua Zhong Liu Za Zhi 30 335 338
20. YL Chen YS Chang JG Chang SM Wu 2009 Genotyping of single nucleotide polymorphism in MDM2 genes by universal fluorescence primer PCR and capillary electrophoresis Anal Bioanal Chem 394 1291 1297